Policy

The FDA's guidance emphasises the potential of NGS methods to mitigate safety risks associated with therapies …

This brief highlights lessons from “Medicaid unwinding" that could help inform work requirement implementation…

This tracker examines Executive Actions taken by the Trump administration that have the potential to impact LG…

This brief provides on overview of funding proposals for domestic HIV programs and initiatives in President Tr…

With competition fierce in the weight loss space, a potential change to how the FDA classifies peptides could …

False claims about the safety of mifepristone are driving legislative and investigative action in Congress, ev…